Experimental drug may stop cancer-induced cachexia
Data from a preclinical study show that AR-42, an experimental drug, may stop cachexia associated with advanced cancers and restore muscle health, according to…
Web Exclusives
Cataract surgery may reduce dizziness in older patients
The improved vision that occurs with cataract surgery may reduce dizziness in older patients, according to a study in Ophthalmic and Physiological Optics. Read…
FDA approves new drugs
· On Nov. 16, the U.S. Food and Drug Administration (FDA) granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who…
FDA approves new treatment for advanced melanoma
On Nov. 10, the U.S. Food and Drug Administration (FDA) approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma…
Wrist fractures may predict more serious fractures in postmenopausal women
Wrist fractures among women younger than 65 may predict more serious fractures in other parts of their bodies later in life, according to a…
Positive results after bariatric surgery in adolescents
Three years after undergoing bariatric surgery, adolescents experienced major improvements in their weight, metabolic health, and quality of life, according to a study in…
FDA approves new drug for severe asthma
On Nov. 4, the U.S. Food and Drug Administration (FDA) approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of…
Guidelines for patients with thyroid conditions
The American Thyroid Association has released guidelines for managing adult patients with thyroid nodules and differentiated thyroid cancer. Access the guidelines.
FDA approves new melanoma treatments
On Oct. 28, the U.S. Food and Drug Administration (FDA) expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant…
FDA approves new drug for hyperkalemia
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved eltassa (patiromer for oral suspension) to treat hyperkalemia. Read more.
FDA approves new drug for pancreatic cancer
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients…
Marijuana use more than doubles from 2001 to 2013
The estimated prevalence of adults who used marijuana in the past year more than doubled in the U.S. between 2001 and 2013 to 9.5%,…
Experimental drug may stop cancer-induced cachexia
Data from a preclinical study show that AR-42, an experimental drug, may stop cachexia associated with advanced cancers and restore muscle health,…
Cataract surgery may reduce dizziness in older patients
The improved vision that occurs with cataract surgery may reduce dizziness in older patients, according to a study in Ophthalmic and Physiological…
FDA approves new drugs
· On Nov. 16, the U.S. Food and Drug Administration (FDA) granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple…
FDA approves new treatment for advanced melanoma
On Nov. 10, the U.S. Food and Drug Administration (FDA) approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat…
Wrist fractures may predict more serious fractures in postmenopausal women
Wrist fractures among women younger than 65 may predict more serious fractures in other parts of their bodies later in life, according…
Positive results after bariatric surgery in adolescents
Three years after undergoing bariatric surgery, adolescents experienced major improvements in their weight, metabolic health, and quality of life, according to a…
FDA approves new drug for severe asthma
On Nov. 4, the U.S. Food and Drug Administration (FDA) approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance…
Guidelines for patients with thyroid conditions
The American Thyroid Association has released guidelines for managing adult patients with thyroid nodules and differentiated thyroid cancer. Access the guidelines.
FDA approves new melanoma treatments
On Oct. 28, the U.S. Food and Drug Administration (FDA) expanded the approved use of Yervoy (ipilimumab) to include a new use…
FDA approves new drug for hyperkalemia
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved eltassa (patiromer for oral suspension) to treat hyperkalemia. Read more.
FDA approves new drug for pancreatic cancer
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to…
Marijuana use more than doubles from 2001 to 2013
The estimated prevalence of adults who used marijuana in the past year more than doubled in the U.S. between 2001 and 2013…
Test Your Knowledge
Cannabis TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.